Chengda Biotechnology, Liaoning Chengda and other newly established biopharmaceutical investment funds.

According to the Qi Cha Cha app, recently, Chengda Biomedical Industry Investment Fund Partnership Enterprise was established with a contribution of 5.02 billion yuan. Its business scope includes private equity funds for equity investment, investment management, and asset management activities. Equity penetration of the Qi Cha Cha shows that the enterprise was jointly funded by Chengda Biomedical and Liaoning Chengda.